Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros










Intervalo de año de publicación
1.
Toxicol In Vitro ; 65: 104809, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32087267

RESUMEN

Disintegrins are low molecular weight cysteine-rich proteins (4-14 kDa) that are isolated mainly from viperid snake venom. Due to their potential as lead compounds for binding and blocking integrin receptors, snake venom disintegrins have become one of the most studied venom protein families. The aim of this study was to obtain disintegrins from C. totonacus venom and evaluate their capability to bind and block integrin receptors. The C. totonacus disintegrin fraction (totonacin) represents two disintegrin isoforms obtained from C. totonacus venom. These disintegrins showed extracellular-matrix (ECM) protein adhesion and migration inhibitory effects on MDA-MB-231 and HMEC-1 cells. Totonacin (3 µM) inhibited MDA-MB-231 cell adhesion to the ECM proteins, fibronectin, vitronectin, and laminin by 31.2, 44.0, and 32.1, respectively. Adhesion inhibition to fibronectin, vitronectin, and laminin observed on HMEC-1 cells was 42.8, 60.8, and 51%, respectively. In addition, totonacin (3 µM) significantly inhibited MDA-MB-231 and HMEC-1 cell migration (41.4 and 48.3%, respectively). Totonacin showed more potent cell adhesion inhibitory activity toward vitronectin in both cell lines. These results suggest a major affinity of totonacin toward αVß3, α8ß1, αVß5, αVß1, and αIIbß3 integrins. In addition, the inhibitory effect observed on MDA-MB-231 and HMEC-1 cell migration reinforces the evidence of an interaction between these disintegrins and αVß3 integrin, which plays a key role in migration and angiogenesis.


Asunto(s)
Venenos de Crotálidos/química , Desintegrinas/farmacología , Proteínas de Reptiles/farmacología , Animales , Adhesión Celular/efectos de los fármacos , Línea Celular , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Crotalus , Desintegrinas/aislamiento & purificación , Humanos , Proteínas de Reptiles/aislamiento & purificación , Cicatrización de Heridas/efectos de los fármacos
2.
Pharmazie ; 73(9): 537-540, 2018 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-30223938

RESUMEN

The ischemia/reperfusion (I/R) process alters metabolic pathways, releasing reactive oxygen species and pro-inflammatory cytokines that cause tissue necrosis and activate cellular apoptotic pathways. Misoprostol (MSP) is a prostaglandin E1 analog that has demonstrated a cytoprotective role in the I/R process. The study objective was to evaluate the effects of MSP on the regulation of pro-inflammatory and oxidative stress mediators in an I/R-induced acute kidney injury rat model. Wistar rats were divided into 3 groups. Sham and I/R were given 1 mL/day of physiological solution; MSP+I/R was given intragastric MSP (300 µg/kg) for 3 days. For I/R and MSP+IR, the renal hilum was clamped for 45 min, followed by 15 h of reperfusion. Renal function tests, pro-inflammatory cytokines, mediators of oxidative stress, and histological analysis were evaluated. Pro-inflammatory cytokine activity was significantly attenuated in the MSP+I/R group. However, there was no statistically significant difference between Sham and MSP. Regarding antioxidant activity, MSP+I/R showed a significant decrease in these mediators compared with Sham and I/R. Histologically, scarce medullary necrosis was observed with a preserved renal cortex in the MSP group.


Asunto(s)
Lesión Renal Aguda/tratamiento farmacológico , Misoprostol/farmacología , Estrés Oxidativo/efectos de los fármacos , Daño por Reperfusión/tratamiento farmacológico , Lesión Renal Aguda/fisiopatología , Animales , Antioxidantes/metabolismo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Pruebas de Función Renal , Masculino , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/fisiopatología
3.
Toxicol In Vitro ; 19(1): 47-53, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15582355

RESUMEN

T-514 (Peroxisomicine A(1)) from Karwinskia humboldtiana is a dimeric hydroxyanthracenone with a highly selective cytotoxic effect on tumor cells. We evaluated the metabolism of this compound in two in vitro systems (liver microsomes and hepatocytes) and assessed the cytotoxicity of its metabolites on normal and tumor cells. Microsomes (12.5, 125 and 250 microg of protein/ml) and hepatocytes (1 x 10(6) cells/ml) were incubated with the toxin (25 microM) for 0.5, 1, 3, 6, 9, 12 and 24 h and the samples were examined using chromatographic analysis and UV spectra. Two metabolites (M1 and M2) were detected in the rat microsomes and one (M1) in the monkey microsomes. The retention times and UV spectra of the peaks were very similar to those of the toxin T-514. M1 was isolated and identified as a mixture of two isomers. The cytotoxicity of the metabolites was evaluated in Chang liver and Hep G2 cells but they did not show the selective cytotoxic effect on tumor cells seen in the original compound.


Asunto(s)
Antracenos/toxicidad , Citotoxinas/toxicidad , Hepatocitos/efectos de los fármacos , Karwinskia/química , Microsomas Hepáticos/efectos de los fármacos , Animales , Células Cultivadas , Cromatografía Líquida de Alta Presión , Perros , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/toxicidad , Cobayas , Haplorrinos , Hepatocitos/patología , Humanos , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Ratones , Microsomas Hepáticos/metabolismo , Ratas , Especificidad de la Especie , Terapia Ultravioleta
4.
Toxicol In Vitro ; 17(1): 19-25, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12537958

RESUMEN

In the present study we have analyzed the production of reactive oxygen species by toxin T-514 of the genus Karwinskia in vitro (primary liver cell cultures and microsomes), as well as their possible role in its cytotoxicity. The role of catalase and superoxide dismutase (SOD) as defense mechanisms against oxidative stress was also studied. Freshly isolated hepatocytes or microsomes were exposed to T-514 in the presence or absence of catalase and SOD. Cytotoxicity was determined by methylthiazoltetrazolium (MTT) reduction. Oxidative stress was evaluated by the dichlorofluorescein diacetate (DCFDA) fluorescent probe and the reduction of ferricytochrome c. Exposure of hepatocytes to toxin T-514 for 2-, 4-, 6- and 24-h periods resulted in a time- and concentration-dependent increase in the suppression of mitochondrial metabolic activity. T-514 induced the production of reactive oxygen species in both hepatocytes and microsomes. Catalase and superoxide dismutase had a protective effect against the cytotoxicity of T-514 in hepatocytes and also inhibited the production of oxygen reactive species in microsomes. The results indicate that oxidative stress mediated by reactive intermediates may be a mechanism by which T-514 induces its cytotoxic effect.


Asunto(s)
Antracenos/efectos adversos , Karwinskia/química , Estrés Oxidativo , Especies Reactivas de Oxígeno , Animales , Catalasa/farmacología , Citotoxinas , Hepatocitos , Hígado/citología , Masculino , Microsomas Hepáticos , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Superóxido Dismutasa/farmacología
5.
Hum Exp Toxicol ; 21(11): 573-7, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12507251

RESUMEN

The efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) was evaluated in workers occupationally exposed to lead (Pb; blood level >50 microg/dL). Ten men were given 600 mg of DMSA per orem daily, for five days. Pb concentrations of whole blood and urine were determined throughout therapy. Hematology analyses, blood chemistry, and urinalysis were obtained at the start of the study, at the end of the DMSA treatment, and at 72 hours after the administration of the final dose. DMSA therapy had no influence on hepatic, hematologic, or renal functions and was effective in decreasing the concentration of blood Pb in all the subjects without adverse drug reactions.


Asunto(s)
Quelantes/uso terapéutico , Intoxicación por Plomo/tratamiento farmacológico , Plomo/orina , Enfermedades Profesionales/tratamiento farmacológico , Succímero/uso terapéutico , Administración Oral , Adulto , Quelantes/administración & dosificación , Quelantes/efectos adversos , Humanos , Plomo/sangre , Intoxicación por Plomo/sangre , Intoxicación por Plomo/orina , Masculino , Enfermedades Profesionales/sangre , Enfermedades Profesionales/orina , Succímero/administración & dosificación , Succímero/efectos adversos , Resultado del Tratamiento
6.
Drug Chem Toxicol ; 24(3): 287-99, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11452400

RESUMEN

Peroxysomicine A1, a novel potential anticancer compound induced cell death in established cell lines and in a primary culture of rat neonatal cardiomyocytes. Non-transformed cells are less sensitive to the compound than transformed cell lines. Fluorescent microscopy of dying cells stained with DNA-specific dyes revealed chromatin condensation and nuclear fragmentation as well as membrane blebbing characteristic of apoptosis. Flow cytometry of cells treated with peroxysomicine A1, demonstrated appearance of cells containing less than 2C DNA, that indicated degradation of nuclear DNA, another hallmark of apoptotic cell death. Z-VAD, a nonspecific caspase inhibitor, prevented DNA fragmentation but not cell death registered by permeabilization of cell outer membrane. Peroxysomicine A1 also inhibited proliferation of various cell lines. Flow cytometry analysis showed significant accumulation of dividing cells in G2/M phases of cell cycle indicating, most likely delay in G2. These results provide initial insight into the mechanisms of action of peroxysomicine A1 and suggest that peroxysomicine A1 is a potent inhibitor of cell proliferation and inducer of apoptosis and may be a useful antineoplastic chemotherapeutic agent.


Asunto(s)
Antracenos/toxicidad , Antineoplásicos Fitogénicos/toxicidad , Fragmentación del ADN/efectos de los fármacos , Clorometilcetonas de Aminoácidos/farmacología , Inhibidores de Caspasas , Ciclo Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , ADN de Neoplasias/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Células HeLa/efectos de los fármacos , Células HeLa/patología , Humanos , Células Jurkat/efectos de los fármacos , Células Jurkat/patología
7.
J Toxicol Clin Toxicol ; 38(7): 697-700, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11192456

RESUMEN

OBJECTIVE: To evaluate the effects of intravenous sodium 2,3-dimercaptopropane-1-sulfonate (DMPS, Dimaval) on urinary excretion of essential trace elements in subjects who received this chelating agent as a mercury challenge test. SUBJECTS: Eleven subjects sought medical attention due to concern with the toxicity of mercury released from dental amalgam fillings. DESIGN: The subjects were given DMPS 3 mg/kg intravenously. Spot urine samples were collected 1 hour before and 1 hour after the DMPS dose for laboratory analysis. In addition to mercury, the urinary excretion of copper, zinc, selenium, magnesium, manganese, molybdenum, chromium, cobalt, and aluminum were measured. RESULTS: A significant increase in urinary excretion of mercury (3- to 107-fold) was observed after the DMPS dose. The DMPS treatment led to a 2- to 119-fold increase in copper excretion; 3- to 43.8-fold in selenium excretion; 1.6- to 44-fold in zinc excretion; and 1.75- to 42.7-fold in magnesium excretion. The excretion of manganese, chromium, cobalt, aluminium, and molybdenum remained unchanged. CONCLUSIONS: In this study, an intravenous DMPS challenge test produced a significant increase in mercury excretion and also led to an increased excretion of copper, selenium, zinc, and magnesium.


Asunto(s)
Quelantes/farmacología , Mercurio/orina , Metales/orina , Oligoelementos/orina , Unitiol/farmacología , Quelantes/administración & dosificación , Quelantes/efectos adversos , Amalgama Dental , Femenino , Humanos , Masculino , Intoxicación por Mercurio/diagnóstico , Unitiol/administración & dosificación , Unitiol/efectos adversos
9.
J Toxicol Clin Toxicol ; 35(1): 83-7, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9022657

RESUMEN

CASE REPORT: A case of intravenous self-administration of elementary mercury is presented. The increase urinary excretion of mercury after treatment with 2,3-dimercaptopropane-1-sulfonate is reported on a 5-year follow-up. No biochemical abnormalities in hepatic or renal function nor clinical pulmonary malfunction have been detected, despite the persistence of metallic densities in the body. The only persistent symptoms are tremor and lower extremity weakness. Any long term benefits of 2,3-dimercaptopropane-1-sulfonate treatment remains to be determined.


Asunto(s)
Antídotos/uso terapéutico , Intoxicación por Mercurio/etiología , Intento de Suicidio , Unitiol/uso terapéutico , Mano/diagnóstico por imagen , Humanos , Inyecciones Intravenosas , Masculino , Mercurio/análisis , Mercurio/orina , Intoxicación por Mercurio/terapia , Persona de Mediana Edad , Radiografía Abdominal , Radiografía Torácica
10.
J Toxicol Clin Toxicol ; 35(6): 653-5, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9365436

RESUMEN

OBJECTIVE: To evaluate clinical symptoms and urinary mercury before and after chelation therapy in subjects with chronic cutaneous mercurous chloride (HgCl; calomel) exposure. SUBJECTS: Twelve women from 19-45 years who had used a facial cream which contained HgCl (5.9%) for 2 to 10 years. DESIGN: Twenty-four hour urine samples were collected for basal urine mercury. All the subjects received a 5-day cycle of oral sodium 2,3 dimercaptopropane-l-sulfonate (Dimaval capsules 100 mg) 200 mg/d on an outpatient basis. The urine mercury excretion was monitored 24 hours after the first dose and 72 hours after the last dose in eight subjects. RESULT: Exanthem and tremor were detected in two of 12 subjects. The range of urine mercury was 180 to 1876 micrograms/g creatinine. A significant increase in the urinary mercury excretion was observed in the first 24 hours after beginning sodium 2,3-dimercaptopropane-1-sulfonate. CONCLUSION: Chronic topical application of 5.9% HgCl cream was associated with clinical mercurialism in two subjects and with high urinary mercury level in all the cases. Sodium 2,3-dimercaptopropane-1-sulfonate was effective in increasing urine mercury.


Asunto(s)
Quelantes/uso terapéutico , Compuestos de Mercurio/envenenamiento , Intoxicación por Mercurio/tratamiento farmacológico , Mercurio/orina , Unitiol/uso terapéutico , Administración Oral , Adulto , Quelantes/administración & dosificación , Cara , Femenino , Humanos , Intoxicación por Mercurio/orina , Persona de Mediana Edad , Pomadas/envenenamiento , Absorción Cutánea/efectos de los fármacos , Espectrofotometría Atómica , Unitiol/administración & dosificación
11.
J Toxicol Clin Toxicol ; 33(6): 717-20, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-8523500

RESUMEN

The purpose of this study was to determine the clinical efficacy of 2,3-dimercapto-1-propane sulfonic acid, Na salt, on the urinary excretion of mercury as well as its possible adverse effects. Ten men with occupational mercury exposure (urinary level of 50 micrograms/g creatinine or more) were assigned to receive 2,3-dimercapto-1-propane sulfonic acid p.o. (DIMAVAL capsules, 100 mg) 300 mg/d for five days. Informed written consent was obtained from each subject. Hematology analyses, blood, chemistry, and urinalysis were obtained at the start of the study, at the end of the 2,3-dimercapto-1-propane sulfonic acid treatment and 72 hours after the administration of the final dose of 2,3-dimercapto-1-propane sulfonic acid. Twenty-four-hour urine mercury levels were closely monitored throughout therapy. All data and measurements before and during drug doses were evaluated by analyses of variance. In all subjects mean urine mercury was significantly increased (p < .05) after pre-2,3-dimercapto-1-propane sulfonic acid treatment. One subject had a moderate hypersensitivity reaction (rash) to 2,3-dimercapto-1-propane sulfonic acid but no other toxic effects were observed.


Asunto(s)
Quelantes/uso terapéutico , Intoxicación por Mercurio/tratamiento farmacológico , Mercurio/orina , Enfermedades Profesionales/inducido químicamente , Unitiol/uso terapéutico , Adulto , Terapia por Quelación , Creatinina/orina , Humanos , Masculino , Intoxicación por Mercurio/orina , Persona de Mediana Edad , Enfermedades Profesionales/orina , Estudios Prospectivos , Unitiol/efectos adversos
12.
Toxicon ; 32(10): 1287-91, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7846701

RESUMEN

Toxin T-514 of Karwinskia humboldtiana has been demonstrated to be hepatotoxic in vivo and in vitro. Recently a diastereoisomer of T-514 has been isolated. In the present study we have evaluated and compared the in vitro hepatoxicity of the diastereoisomer of T-514 using primary cultures of rat hepatocytes. Cytotoxicity was evaluated by release of cytoplasmic enzyme lactate dehydrogenase (LDH), and mitochondrial metabolic function (MTT reduction). The diastereoisomer was shown to be almost as hepatoxic in vitro as toxin T-514.


Asunto(s)
Antracenos/toxicidad , Citotoxinas/toxicidad , Hígado/efectos de los fármacos , Análisis de Varianza , Animales , Animales Recién Nacidos , Antracenos/química , Células Cultivadas , Citoplasma/enzimología , Citotoxinas/química , Relación Dosis-Respuesta a Droga , L-Lactato Deshidrogenasa/metabolismo , Hígado/citología , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/enzimología , Plantas Medicinales , Plantas Tóxicas , Ratas , Ratas Sprague-Dawley , Rhamnus , Estereoisomerismo
13.
Toxicology ; 73(2): 191-201, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1609429

RESUMEN

The present study was undertaken to assess and compare the in vitro cytotoxicity of toxins T-514 and T-544 of buckthorn (Karwinskia humboldtiana) using primary cultures of rat hepatocytes and keratinocytes. Cell cultures were exposed to 6, 12, 25 and 50 microM toxins for 2-, 4-, 6- and 24-h periods. Cytotoxicity was determined by release of the cytoplasmic enzyme, lactate dehydrogenase (LDH), in culture media, methylthiazoltetrazolium (MTT) reduction and neutral red (NR) uptake. An increase in LDH leakage was observed in liver cell cultures as early as 2 h with 50 microM T-544 and with 6 microM T-514 and T-544 at 6 h and 24 h, respectively. In the NR assay the toxicity was evident at 2 h with 12 microM T-514 and T-544 and with 6 microM concentrations of both toxins at 6 h. On the other hand, a decrease in MTT reduction was detected at 4 h with 50 microM concentrations of both toxins and with 25 microM T-544 and 12 microM T-514 at 6 h and 6 microM T-514 and T-544 at 24 h. Both toxins were shown to be highly hepatotoxic; T-514 was more toxic than T-544. In the skin cell cultures, the toxicity of the toxins was not as severe and was not expressed until 12 h of exposure.


Asunto(s)
Antracenos/toxicidad , Queratinocitos/efectos de los fármacos , Hígado/efectos de los fármacos , Plantas Medicinales , Plantas Tóxicas , Piranos/toxicidad , Rhamnus , Animales , Animales Recién Nacidos , Células Cultivadas , L-Lactato Deshidrogenasa/análisis , Hígado/citología , Mitocondrias Hepáticas/efectos de los fármacos , Ratas
14.
Toxicology ; 73(3): 259-67, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1631903

RESUMEN

The present study was undertaken to assess and compare the in vitro cytotoxicity of toxins T-514 and T-544 of Buckthorn (Karvinskia humboldtiana) using primary cultures of rat hepatocytes and keratinocytes. Cell cultures were exposed to 6, 12, 25 and 50 microM concentrations of the toxins for 2, 4, 6 and 24-h periods. Cytotoxicity was determined by release of the cytoplasmic enzyme, lactate dehydrogenase (LDH), in culture media, methylthiazoltetrazolium (MTT) reduction and neutral red (NR) uptake. An increase in LDH leakage was observed in liver cell cultures as early as 2 h with 50 microM T-544 and with 6 microM T-514 and T-544 at 6 h and 24 h, respectively. In the NR assay the toxicity was evident at 2 h with 12 microM T-514 and T-544 and with 6 microM concentrations of both toxins at 6 h. On the other hand, a decrease in MTT reduction was detected at 4 h with 50 microM concentrations of both toxins and with 25 microM T-544 and 12 microM T-514 at 6 h and 6 microM T-514 and T-544 at 24 h. Both toxins were shown to be highly hepatotoxic; T-514 was more toxic than T-544. In the skin cell cultures, the toxicity of the toxins was not as severe and was not expressed until 12 h of exposure.


Asunto(s)
Antracenos/toxicidad , Hígado/efectos de los fármacos , Plantas Medicinales , Plantas Tóxicas , Piranos/toxicidad , Rhamnus/química , Piel/efectos de los fármacos , Animales , Membrana Celular/efectos de los fármacos , Células Cultivadas , L-Lactato Deshidrogenasa/metabolismo , Hígado/metabolismo , Rojo Neutro/metabolismo , Ratas , Ratas Endogámicas , Piel/metabolismo
15.
Rev. invest. clín ; 38(4): 407-9, oct.-dic. 1986. tab
Artículo en Español | LILACS | ID: lil-40660

RESUMEN

Se efectuó un estudio retrospectivo de las intoxicaciones registradas en el Hospital Universitario "Dr. José E. González" (H.U.) de 1980 a 1984 en el cual se consideraron los siguientes puntos: edad y sexo del paciente, tipo y modo de intoxicación, mortalidad y total de intoxicaciones en este periodo. El ingreso total de pacientes al H.U. fue de 182,247 del cual el 0.26% (477) correspondió a intoxicaciones siendo las más frecuentes: petróleo (Kerosene), cáusticos, salicilatos, alcohol etílico y atropina. El modo de intoxicación fue accidental en un 90% de los casos e intento de suicidio en 10%. La mayoría fueron niños (70%) y un 30% adultos; 277 masculinos y 200 femeninos. La mortalidad por intoxicaciones fue de 1.25% (6 de 477 pacientes) y las substancias relacionadas con estas muertes fueron digitálicos (3), salicilatos (1), talio (1) y cáusticos (1)


Asunto(s)
Humanos , Masculino , Femenino , Intoxicación/epidemiología , Accidentes Domésticos , México , Intento de Suicidio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...